Evidence map›Paper›PMID 40796174›Full record

ArticleThe Journal of clinical endocrinology and metabolism2026

Compartment-specific Metabolic Alterations to Insulin Reflect Adiposity-driven Variation and Predict Type 2 Diabetes.

Magdalena Sevilla-González, Paul A Hanson, Jesse Islam, Sarah Hsu, Michael A Tsoukas, Errol B Marliss, Alexander P Reiner, Michel Gravel, Charles Kooperberg, Clary B Clish and 4 more

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Magdalena Sevilla-GonzálezClinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0001-6135-9998
Paul A HansonClinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.
Jesse IslamDepartment of Human Genetics, McGill University, Montreal, QC, Canada H3A 0C7.
Sarah HsuClinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.
Michael A TsoukasMetabolic Disorders and Complications Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada H4A 3J.
Errol B MarlissMetabolic Disorders and Complications Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada H4A 3J.
Alexander P ReinerDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Michel GravelMcGill Genome Centre, McGill University, Montreal, QC, Canada H3A 2T8.
Charles KooperbergDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Clary B ClishMetabolomics Platform, The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.ORCID 0000-0001-8259-9245
Alisa K ManningClinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.
Rob SladekDepartment of Human Genetics, McGill University, Montreal, QC, Canada H3A 0C7.ORCID 0000-0002-2730-1204
James B MeigsDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Sergio A BurgosDivision of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada H3A 1A1.ORCID 0000-0003-0569-4307

Funding

WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER: TASK AREA B - LONG LIFE STUDY VISIT 2 LIMITED HOME VISIT75N92021D00001 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ANDERSON, GARNET L. · 2021 to 2025
$52.0M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A275N92021D00002 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI WACTAWSKI-WENDE, JEAN · 2021 to 2025
$6.9M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC) - TO EXERCISE OPTION PERIOD ONE (1) AND REVISE CONTRACT ARTICLES.75N92021D00004 · NHLBI · STANFORD UNIVERSITY · PI STEFANICK, MARCIA · 2021 to 2025
$6.5M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC) - TO EXERCISE OPTION PERIOD ONE (1) AND REVISE CONTRACT ARTICLES.75N92021D00003 · NHLBI · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA · 2021 to 2025
$5.0M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC) - TO EXERCISE OPTION PERIOD ONE (1) AND REVISE CONTRACT ARTICLES.75N92021D00005 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI VITOLINS, MARA · 2021 to 2025
$4.2M
TOPMed Omics of Type 2 Diabetes and Quantitative TraitsUM1DK078616 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MANNING, ALISA KNODLE · 2021 to 2025
$3.8M
American Diabetes Association 9-22-PDFPM-04American Diabetes Association NIDDK UM1 DK078616Congressionally Directed Medical Research ProgramsNHLBI NIH HHS 75N92021D00001NHLBI NIH HHS 75N92021D00002NIDDK NIH HHS UM1 DK078616NIH HHSWHI NIH HHS 75N92021D00003WHI NIH HHS 75N92021D00004WHI NIH HHS 75N92021D00005
6 · The paper itself

Abstract

contextThe metabolic mechanisms underlying insulin resistance are not fully understood. Metabolomic profiling can reveal compartment-specific variations and identify individuals at risk for type 2 diabetes (T2D).

objectiveTo characterize insulin-induced metabolomic changes during a hyperinsulinemic-euglycemic clamp and evaluate a derived risk score's predictive value for T2D. DESIGN, SETTING, AND

participantsClamp studies were conducted in 80 adults (38 with T2D, 42 without) to measure plasma and muscle metabolites in fasting and hyperinsulinemic states. An insulin resistance metabolomic score was developed and tested in a prospective case-control study (367 cases, 910 controls) from the Women's Health Initiative (28.5-year follow-up).

main outcome measuresMetabolite changes during hyperinsulinemia and incident T2D.

resultsHyperinsulinemia altered 79.5% of plasma metabolites (notably fatty acids, lactate, and pyruvate) and 15.8% of muscle metabolites (eg, branched-chain and aromatic amino acids). T2D was associated with higher triglycerides and lower tricarboxylic acid intermediates during clamp. Adiposity amplified insulin-induced increases in plasma lipids. The risk score predicted incident T2D (hazard ratio, 1.20 per SD; 95% CI, 1.09-1.32; P = 7.4 × 10-4).

conclusionCompartment-specific metabolic responses to insulin are shaped by adiposity and predict future T2D risk, supporting use of metabolomic signatures for early identification and prevention.

Indexed as

AdiposityDiabetes Mellitus, Type 2HyperinsulinismInsulinInsulin ResistanceAdultAgedCase-Control StudiesFemaleFollow-Up StudiesGlucose Clamp TechniqueHumansMaleMetabolomicsMiddle AgedMuscle, SkeletalInsulinbiomarkershyperinsulinemic–euglycemic clampinsulin resistancemetabolomicsskeletal muscletype 2 diabetes

Identifiers

PMID40796174
PMCPMC13501874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.